Exhibit 99- 6g
This is the form of a material change report required under Section 85(l) of the
Securities Act.
                                    FORM 27

                        BRITISH COLUMIBIA SECURITIES ACT

             MATERIAL CHANGE REPORT UNDER SECTION 85(l) OF THE ACT

NOTE:    This form is intended as a guideline. A letter or other document may be
         used if the substantive requirements of this form are complied with.

NOTE:    Every report  required to be filed under Section 85(l) of the Act shall
         be sent to the  Commission in an envelope  addressed to the  Commission
         and marked "Continuous Disclosure".

NOTE:    WHERE THIS REPORT IS FILED ON A CONFIDENTIAL BASIS PUT AT THE BEGINNING
         OF THE  REPORT  IN BLOCK  CAPITALS  "CONFIDENTIAL  - SECTION  85",  AND
         EVERYTHING  THAT IS REQUIRED TO BE FILED SHALL BE PLACED IN AN ENVELOPE
         ADDRESSED TO THE SECRETARY OF THE COMMISSION MARKED "CONFIDENTIAL".

Item 1.  Reporting Issuer

         State the full name and  address of the  principal  office in Canada of
         the reporting issuer:

         Softcare EC.Com Inc. (the "Company")
         Suite 107 - 980 West 1st Street
         North Vancouver, BC V7P 3N4

Item 2.  Date of Material Change

         March 3, 2000

Item 3.  Press Release

         The Press Release dated March 3, 2000 was disseminated and forwarded to
         the  Canadian  Venture  Exchange  by the  Company.

         A copy of the Press Release is attached as Schedule "A".

Item 4.  Summary of  Material  Change

         The Company announced it has signed an engagement letter with Canaccord
         Capital  Corporation  pursuant to which Canaccord Capital  Corporation,
         Haywood Securities Inc. and Research Capital  Corporation will offer to
         sell upto 1.3 million special  warrants at a price of $3.75 per special
         warrant.



                                      -1-
<PAGE>



Item 5.  Full Description of Material Change

         Supplement the summary  required under item 4 with the disclosure which
         should be  sufficiently  complete to enable a reader to appreciate  the
         significance  of  the  material  change  without   reference  to  other
         material.  Management is in the best  position to determine  what facts
         are significant  and must disclose those facts in a meaningful  manner.
         See also item 7.

         The  description  of the  significant  facts  relating to the  material
         change will  therefore  include  some or all of the  following:  dates,
         parties, terms and conditions,  description of any assets,  liabilities
         or capital affected,  purpose,  financial or dollar values, reasons for
         the  change,  and a  general  comment  on the  probable  impact  on the
         reporting  issuer or its  subsidiaries.  Specific  financial  forecasts
         would not normally be required to comply with this form.

         The above list merely described examples of some of the facts which may
         be  significant  The list is not intended to be inclusive or exhaustive
         of the information required in any particular situation.

         For a full description of the material change, see Schedule "A",

Item 6.  Reliance on Section 85(2) of the Act

         If the report is being  filed on a  confidential  basis in  reliance of
         Section 85(2) of the Act, state the reasons for such reliance.

         INSTRUCTION:

         Refer to Section 85(3) of the Act concerning continuing  obligations in
         respect of reports filed pursuant to this subsection.

         Not Applicable.

Item 7.  Omitted  Information

         In certain  circumstances  where a material  change has  occurred and a
         material change report has been or is about to be filed but s. 85(3) of
         the  Act  will no  longer  be  relied  upon,  a  reporting  issuer  may
         nevertheless  believe one or more significant facts otherwise  required
         to  be  disclosed  in  the  material   change   report   should  remain
         confidential and not be disclosed or not be disclosed in full detail in
         the material change report.

         State  whether  any  information  has been  omitted  on this  basis and
         provide  the  reasons for any such  omission  in  sufficient  detail to
         permit the Commission to exercise its discretion  pursuant to s. 169(3)
         of the Act.

         The reasons for the  omission  may be  contained  in a separate  letter
         filed as provided in section 153 of the Securities Rules.

         Not Applicable.



                                      -2-
<PAGE>



Item 8.  Senior Officers

         The  following  Senior  Officer of the Company is  available  to answer
         questions regarding this report:

         Martyn A.  Armstrong,  President
         Suite 107 - 980 West 1st Street
         North Vancouver, BC V7P 3N4
         Phone: (604) 983-8083

Item 9.  Statement of Senior Officer

         The  foregoing  accurately  discloses the material  change  referred to
         herein.

Dated at North Vancouver, BC, this l4th day of March, 2000.

                                        SOFTCARE EC.COM INC,

                                        Per:


                                        "Martyn A. Armstrong"
                                        -----------------------------------
                                        Martyn A. Armstrong
                                        President and Director












                                      -3-
<PAGE>
                                  SCHEDULE "A"

(COMPANY LETTERHEAD)

                                                       Shares Issued: 15,062,028
                                                       Fully Diluted: 17,562,728
                                                                Symbol; SCE-CDNX
                                                                        NR-00-10
                 SoftCare Announces Brokered Private Placement

North  Vancouver,  British  Columbia,  March 3, 2000 -  SoftCare  EC.Com  (CDNX:
"SCE"),  www.softcare.com,  is  pleased  to  announce  that  it  has  signed  an
engagement letter with Canaccord Capital Corporation pursuant to which Canaccord
Capital  Corporation,  Haywood Securities Inc. and Research Capital  Corporation
(the "Agents") will offer and sell to investors up to 1,300,000 special warrants
(the "Special Warrants"), at a price of $3.75 per Special Warrant, for estimated
gross  proceeds of  $4,875,000.  Each  Special  Warrant is  exercisable,  for no
additional  consideration,  into a unit  consisting of a share and one-half of a
share purchase warrant. Each whole share purchase warrant (a "Warrant") entitles
the holder to purchase  one common  share of the Company at a price of $4.25 per
share for one year from the day (the  "Offering  Day") on which the Agents offer
and sell the Special Warrants. If all of the Warrants are exercised, the maximum
gross proceeds from the exercise of the Warrants will be $2,762,500.

In consideration for the services to be provided by the Agents,  the Company has
agreed to pay the Agents a cash commission  equal to 8% of the gross proceeds of
the sale of the Special  Warrants  plus that number of share  purchase  warrants
(the Agents' Warrants) equal to 10% of the number of Special Warrants sold. Each
Agents'  Warrant  will  entitle the Agents to purchase  one common  share of the
Company at a price of $3.75 per share for a period of one year from the Offering
Day.  The  Agents  have also been  granted  the  option to  solicit  and  accept
subscriptions for up to an additional 195,000 Special Warrants.

The  private  placement  is subject to  regulatory  approval  from,  and will be
completed in accordance with the rules of, the Canadian Venture Exchange.

About SoftCare

SoftCare develops business  relationship  management software allowing companies
to conduct  business-to-business  e-commerce  and the  creation of B2B  industry
portals.  Our e-business  management software is open and scaleable allowing for
the integration with existing and future technologies,  lowering operating costs
and streamlining the supply chain while delivering benefits to all your business
e-trading relationships.

On Behalf of the Board of Directors,


Martyn Armstrong, President & CEO


For More Information Contact:


Clive Massey                            Joanna Longo
SoftCare EC.Com Inc.                    The Equicom Group Inc.
604 983 8083 tel                        416 815 0700 tel
604 983 8056 fax                        416 815 0080 fax
cmassey@softcare.com                    jlongo@equicomgroup.com

 SoftCare EC.com, Inc. Suite 107-980 West 1st Str, North Vancouver, BC V7P 3N4
       Tel: (604) 983-8083 Fax: (604) 983-8056 Toll Free: 1-888-SOFTCARE
                                www.softcare.com

SoftCare  EC.Com,  Inc. relies on litigation  protection for statements that are
not historical  facts but are  forward-looking  statements  involving  known and
unknown  risks  and  uncertainties  that  could  cause  actual  results  to vary
materially.



<PAGE>